Correction to:: Impact of risk minimisation measures on the use of strontium ranelate in Europe: a multi-national cohort study in 5 EU countries by the EU-ADR Alliance (Osteoporosis International, (2019), 10.1007/s00198-019-05181-6)

DSpace/Manakin Repository

Correction to:: Impact of risk minimisation measures on the use of strontium ranelate in Europe: a multi-national cohort study in 5 EU countries by the EU-ADR Alliance (Osteoporosis International, (2019), 10.1007/s00198-019-05181-6)
 
Berencsi, K; Sami, A; Ali, M S; Marinier, K; Deltour, N; Perez-Gutthann, S; Pedersen, L; Rijnbeek, P; Van der Lei, J; Lapi, F; Simonetti, M; Reyes, C; Sturkenboom, M C J M; Prieto-Alhambra, D
(2020) Osteoporosis International, volume 31, issue 4, pp.
(Comment)
Abstract
The original version of this article, published on 26 November 2019 contained a mistake. An author’s name was misspelled. The correct author name reads as follows: Susana Perez-Gutthann. The original article has been corrected.
Download/Full Text
The full text of this publication is not available.
Version on publisher website for UU-students and staff
Version on publisher website
 
Keywords: Endocrinology, Diabetes and Metabolism, Published Erratum
DOI: https://doi.org/10.1007/s00198-020-05314-2
ISSN: 0937-941X
Publisher: Springer London
(Peer reviewed)